Improving cardiovascular risk reduction for primary prevention--utility of lifetime risk assessment

Area of Science:

• Cardiology and Cardiovascular Disease Prevention
• Medical Risk Assessment and Decision Making

Background:

• Traditional cardiovascular risk assessments often rely on short-term predictions, which can be significantly influenced by patient age.
• The clinical utility of short-term versus lifetime risk estimates for coronary heart disease (CHD) requires comprehensive review.

Purpose of the Study:

• To review the evidence comparing short-term risk assessments with lifetime risk estimates for overall coronary heart disease (CHD) burden.
• To evaluate how different cardiovascular risk assessment approaches impact clinical decision-making.

Main Methods:

• A systematic literature review of publications from the last 6 years was conducted.
• Search terms included "cardiovascular prevention," "Framingham risk scoring," "lifetime risk," and "cardiovascular risk assessment."
• 98 publications were evaluated to analyze variations in risk estimation and clinical impact.

Main Results:

• Lifetime risk estimates effectively mitigate the impact of age, which heavily influences traditional short-term cardiovascular risk predictions.
• Evidence suggests lifetime risk assessment offers a more comprehensive view of an individual's overall cardiovascular risk burden.

Conclusions:

• Lifetime risk estimates for CHD are potentially more clinically relevant than short-term estimates for assessing an individual's total risk.
• Utilizing lifetime risk assessment may prevent delays in initiating crucial therapeutic interventions to reduce cardiovascular events.
• Communicating the distinction between short-term and lifetime risk is important for primary care patients.